Bleeding Symptoms of Carriers of Hemophilia A and B

This study has been completed.
Sponsor:
Information provided by:
Sahlgrenska University Hospital, Sweden
ClinicalTrials.gov Identifier:
NCT01029808
First received: December 9, 2009
Last updated: July 19, 2011
Last verified: July 2011
  Purpose

To collect and analyze data on female carriers of severe and moderate hemophilia A and B.


Condition
Hemophilia

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: Bleeding Symptoms of Carriers of Hemophilia A and B

Resource links provided by NLM:


Further study details as provided by Sahlgrenska University Hospital, Sweden:

Primary Outcome Measures:
  • Bleeding tendency in carriers of severe and moderate haemophilia compared to a control group. [ Time Frame: Five years ] [ Designated as safety issue: No ]

Estimated Enrollment: 200
Study Start Date: December 2009
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Carriers of severe and moderate hemophilia A and B

Criteria

Inclusion Criteria:

  • Female carriers of hemophilia A and B.

Exclusion Criteria:

  • Pregnancy.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01029808

Locations
Sweden
Sahlgrenska university hospital
Göteborg, Sweden, 41345
Sponsors and Collaborators
Sahlgrenska University Hospital, Sweden
  More Information

No publications provided

Responsible Party: Anna Olsson/MD, Department of hematology and coagulation, Sahlgrenska university hopsital
ClinicalTrials.gov Identifier: NCT01029808     History of Changes
Other Study ID Numbers: VGAO002
Study First Received: December 9, 2009
Last Updated: July 19, 2011
Health Authority: Sweden: Regional Ethical Review Board

Keywords provided by Sahlgrenska University Hospital, Sweden:
carriers of hemophilia

Additional relevant MeSH terms:
Hemophilia A
Hemorrhage
Blood Coagulation Disorders, Inherited
Blood Coagulation Disorders
Hematologic Diseases
Coagulation Protein Disorders
Hemorrhagic Disorders
Genetic Diseases, Inborn
Pathologic Processes
Factor VIII
Coagulants
Hematologic Agents
Therapeutic Uses
Pharmacologic Actions

ClinicalTrials.gov processed this record on April 17, 2014